Impressive presentations of new cell technologies at well-attended ‘Ziekenhuis van de Toekomst’ event
A new knee with your own cartilage cells? Or a world where there is no shortage of donor organs? It sounds like future music, but during the well-attended public event ‘Ziekenhuis van de Toekomst’ (Hospital of the Future) on Tuesday 1 October at UMC Utrecht, it turned out that reality is closer than you think.
Regenerative medicine
The theme of the evening was regenerative medicine. This aims to develop new treatments that take advantage of the body’s ability to repair damaged tissue itself. During the evening, there were very interesting presentations and demos that gave visitors a unique insight into the future of medicine.
Stem cells
After the introduction by Carina Hilders, chairman of the Executive Board of UMC Utrecht, and Stephan van Duin, University lecturer and biologist Joost Fledderus gave a clear explanation of what stem cells are, why they are so important for medicine and how they could change the future of treatments. Stem cells, form the basis of the human body and through division are able to change into other cell types.
A new knee with your own cartilage cells
Orthopaedic surgeon Roel Custers gave visitors more insight into the effective treatment of osteoarthritis (a decrease in cartilage around a joint) through the use of stem cell cartilage transplantation.
Repairing DNA
Next, paediatrician Sabine Fuchs told an impressive story about treating children with metabolic diseases. These are often serious diseases caused by a mistake in the DNA. Advances in genetic techniques are making it increasingly possible to repair faults in DNA.
Alternatives to dialysis and repairing brain damage
After the break with interesting demos, nephrologist Karin Gerritsen explained her research on how we can make dialysis better, more sustainable and less stressful for patients by using smart materials, chip technology and kidney cells. Paediatric neonatologist Manon Benders explained how stem cells can repair brain damage in newborns.
The costs of innovation
Finally, health economics researcher Renske ten Ham addressed the cost side. Cell and gene therapies are often much more expensive than regular treatments, but essential for curing a patient. Renske develops models to support reimbursement decisions.
Impressive evening
Overall, a very impressive evening during the Utrecht Science Week, in which visitors were taken through the wonderful innovations within the field of medicine at UMC Utrecht, in cooperation with many other parties and organisations.
UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.
While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.
Are you participating in the Utrecht Marathon or are you a keen runner? Register for the Running Symposium on March 19th.
On Sunday, May 31st, Utrecht Science Park will once again be the setting for the Utrecht Marathon. Thousands of runners will line up at the starting line to achieve a fantastic feat: running a quarter, half, or full marathon! To help you prepare optimally, the Utrecht Science Park Foundation, in collaboration with partners Utrecht University, UMC Utrecht, Utrecht University of Applied Sciences, and Olympos Sports Centre, is organizing a running symposium where you’ll be informed and inspired to get the most out of your running performance.
Applications Now Open for UtrechtInc Validation Programmes
Have you ever wondered what it takes to turn research or an idea into a startup? The validation programmes offered by UtrechtInc may provide the first step. Applications are now open.
Utrecht Science Park researchers receive prestigious Cancer Grand Challenge grants
Several research groups, including researchers from UMC Utrecht, the Princess Máxima Center, and the Hubrecht Institute, have been selected for a prestigious Cancer Grand Challenge (CGC) grant. Cancer Grand Challenges was co-founded in 2020 by Cancer Research UK and the National Cancer Institute in the United States. The initiative supports international, multidisciplinary research teams focusing on major challenges in cancer research.